Sonic Healthcare Limited (FRA:SAB)

Market Cap	6.10B -6.0%
Revenue (ttm)	5.92B +11.7%
Net Income	306.44M -1.1%
EPS	0.63 -2.7%
Shares Out	n/a
PE Ratio	19.90
Forward PE	15.76
Dividend	0.62 (5.17%)
Ex-Dividend Date	Mar 4, 2026

Volume	n/a
Average Volume	123
Open	12.13
Previous Close	12.07
Day's Range	12.13 - 12.13
52-Week Range	11.36 - 15.78
Beta	n/a
RSI	47.27
Earnings Date	May 19, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Health Services
• Founded: 1934
• Employees: 45,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SAB

Financial Performance

In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.

Financial numbers in AUD